Nippon Shokubai Co., Ltd.
2,571.50
JPY
-26.50
(-1.02%)
ISIN
JP3715200006
Return %
Stock
S&P 500
1Y
42.39
14.20
3Y
88.91
81.12
5Y
77.65
68.34
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.Company Description
- CEO
- Kazuhiro Noda
- Full Time Employees
- 4,880
- Sector
- Process industries
- Industry
- Chemicals: major diversified
- Address
- Kogin Building Osaka OS Japan 541-0043
- IPO Date
- May 6, 1952
- Website
- shokubai.co.jp
- Similar Companies
- Business
- Nippon Shokubai Co., Ltd. manufactures and sells a broad range of basic and specialty chemicals, synthetic resins, and catalysts primarily in Japan and internationally through its Materials Business and Solutions Business segments; core products include superabsorbent polymers such as AQUALIC CA and CS for hygiene and horticultural applications, acrylic acids and esters, maleic anhydride and derivatives like succinic acid and N-phenylmaleimide (IMILEX-P), ethylene oxide and glycols, ethanolamines, process catalysts for acrolein and ethylene oxide production, polycarboxylate ether polymers (AQUALOC) for concrete admixtures, oxazoline group-containing emulsions (EPOCROS K Series), polyethyleneimine (EPOMIN), secondary alcohol ethoxylates (SOFTANOL), automotive catalysts, De-NOx catalysts, dioxin decomposition catalysts, electrolyte materials for lithium-ion batteries (IONEL LF-101), acrylic resins for optical films (ACRYVIEWA), fine particles like EPOSTAR series and SEAHOSTAR silica, and polymers for color filters (ACRYCURE); the company also offers electronic information materials, pharmaceutical intermediates, water-soluble polymers, and contract development and manufacturing services for medium-sized molecule APIs including oligonucleotides and peptides. Founded in 1941 and headquartered in Osaka, Japan, with key facilities including the Tokyo Office, Kawasaki Plants (Chidori and Ukishima), Himeji Plant and Research Center, and Suita Research Center, Nippon Shokubai operates globally with exports to regions including the US, Europe, and Asia, targeting industries such as hygiene products, construction, automotive, electronics, pharmaceuticals, cosmetics, energy storage, and environmental treatment. In recent developments, the company completed the acquisition of Emulsion Technology Co., Ltd. (E-TEC) from JSR Corporation for ¥7.2 billion on April 1, 2025, to bolster its construction chemicals portfolio through E-TEC's emulsion polymerization and compounding technologies; it acquired all shares of Lilac pharma Inc. on December 9, 2024, making it a wholly-owned subsidiary to advance lipid nanoparticle (liposome) technologies like iLiNP Microfluidic Device for cosmetics and pharmaceuticals via joint R&D since 2019; additionally, Nippon Shokubai strengthened its domestic supply chain for lithium bis(fluorosulfonyl)imide (LiFSI) electrolytes in 2024 and published its TechnoAmenity Report 2024 emphasizing sustainability.